Acelyrin Inc (SLRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SLRN | CCCC | CAMP | ||
| Company | Acelyrin Inc | C4 Therapeutics Inc | Camp4 Therapeutics Corp | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 2.24 | 2.57 | 4.52 | ||
| High | 2.36 | 2.60 | 4.52 | ||
| Low | 2.20 | 2.39 | 4.31 | ||
| Latest | 2.27 | 2.41 | 4.31 | ||
| Change | +0.04 | -0.21 | -0.25 | ||
| % Change | +1.79% | -8.02% | -5.48% | ||
| Volume | 4,076,500 | 1,632,700 | 59,600 | ||
| 20-Day Average Volume | 1,091,300 | 2,844,370 | 434,035 | ||
| Previous Close | 2.23 | 2.62 | 4.56 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 2.33 | 2.84 | 4.96 | ||
| 20-Day Raw Stochastic | 45.16% | 1.40% | 10.88% | ||
| 20-Day Relative Strength | 47.29 | 47.01 | 45.19 | ||
| Weighted Alpha | -28.45 | +9.96 | -45.56 | ||
| Today's Opinion | 88% Sell | 56% Buy | 40% Buy | ||
| Previous Opinion | 88% Sell | 72% Buy | 40% Buy | ||
| Last Month's Opinion | 100% Sell | 8% Buy | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +8.61% since 05/13/25 | -10.74% since 03/20/26 | -13.80% since 03/20/26 | ||
| Low | 1.95 on 05/15/25 | 2.39 on 03/27/26 | 4.31 on 03/27/26 | ||
| High | 2.36 on 05/20/25 | 2.81 on 03/23/26 | 5.09 on 03/23/26 | ||
| 1-Month | |||||
| %Chg | +3.18% since 04/17/25 | -10.74% since 02/27/26 | -4.01% since 02/27/26 | ||
| Low | 1.95 on 05/15/25 | 2.39 on 03/27/26 | 3.89 on 03/03/26 | ||
| High | 2.65 on 05/01/25 | 3.82 on 03/09/26 | 7.75 on 03/09/26 | ||
| 3-Month | |||||
| %Chg | +4.61% since 02/20/25 | +13.68% since 12/26/25 | -27.68% since 12/26/25 | ||
| Low | 1.95 on 05/15/25 | 1.69 on 02/05/26 | 3.30 on 01/27/26 | ||
| High | 2.94 on 04/02/25 | 3.82 on 03/09/26 | 7.75 on 03/09/26 | ||
| 6-Month | |||||
| %Chg | -48.76% since 11/20/24 | +8.07% since 09/26/25 | +44.63% since 09/26/25 | ||
| Low | 1.85 on 02/11/25 | 1.69 on 02/05/26 | 2.85 on 10/02/25 | ||
| High | 5.03 on 11/25/24 | 3.82 on 03/09/26 | 7.75 on 03/09/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 229,166 | 235,163 | 223,771 | ||
| Shares Outstanding, K | 100,954 | 97,578 | 51,919 | ||
| Annual Sales | 0 | 35,950,000 | 3,500,000 | ||
| Annual Net Income | -248,230,000 | -104,990,000 | -80,400,000 | ||
| Last Quarter Sales | 0 | 11,020,000 | 350,000 | ||
| Last Quarter Net Income | -55,260,000 | -20,490,000 | -40,280,000 | ||
| 60-Month Beta | 1.07 | 2.85 | 0.36 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.55 on 05/14/25 | -0.18 on 02/26/26 | -0.87 on 03/05/26 | ||
| Latest Earnings Date | 08/12/25 | 05/06/26 | 05/12/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||